Nektar Therapeutics Long Term Deferred Assets (Quarterly) Insights

Nektar Therapeutics (NKTR)

36.20 -1.48 (-3.93%) USD | NASDAQ | Jan 20, 16:00

36.19 -0.01 (-0.03%) After-Hours: 20:00

View Long Term Deferred Assets (Quarterly) for NKTR.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Rigel Pharmaceuticals, Inc.	--
Insmed, Inc.	--
Eli Lilly & Co.	Upgrade
Ironwood Pharmaceuticals, Inc.	Upgrade
Lyell Immunopharma, Inc.	--